EDUCATIONAL OBJECTIVES

At the completion of this course, participants should be able to:

• Identify clinical trial evidence that allows for the personalization of care in the management of early and advanced forms of breast cancer according to breast cancer phenotype
• Implement current and evolving roles for prognostic and predictive biomarkers to stratify risk and inform clinical decision making in the management of breast cancer 
• List recent clinical trial results concerning the use of novel breast cancer treatment strategies

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For more information please visit the official event page.